Stay updated on Safety and Efficacy of Aflibercept in AMD Clinical Trial
Sign up to get notified when there's something new on the Safety and Efficacy of Aflibercept in AMD Clinical Trial page.

Latest updates to the Safety and Efficacy of Aflibercept in AMD Clinical Trial page
- ChecktodayChange DetectedThe clinical-trial record for the CANDELA study is displayed, with details on its design, participants, treatment arms, outcomes, and study locations. The record also includes publication and data-sharing information, study dates, and protocol documents.SummaryDifference68%

- Check7 days agoChange DetectedThe ClinicalTrials.gov footer now displays revision v3.8.0 instead of v3.7.2.SummaryDifference0.2%

- Check21 days agoChange DetectedA general NIH banner announces a website transition and related terminology updates. The site revision changes from v3.7.1 to v3.7.2.SummaryDifference1%

- Check35 days agoChange DetectedThe footer revision identifier changed from v3.7.0 to v3.7.1 while the page continued to display a 403 error.SummaryDifference0.2%

- Check49 days agoChange DetectedThe page now shows a 403 Forbidden error, replacing the study content with a standard error page and signaling that access to the record is blocked.SummaryDifference18%

- Check56 days agoChange DetectedThe page footer now shows Revision: v3.7.0, replacing the previous Revision: v3.6.6 as part of a minor platform update. No observed changes to trial data or visible content.SummaryDifference0.0%

Stay in the know with updates to Safety and Efficacy of Aflibercept in AMD Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Safety and Efficacy of Aflibercept in AMD Clinical Trial page.